70024-40-7

  • Product Name:Terazosin hydrochloride dihydrate
  • Molecular Formula:C19H25N5O4.HCl.2(H2O)
  • Purity:99%
  • Molecular Weight:441.915
Inquiry

Product Details

pd_meltingpoint:271-274 °C

Appearance:white or off-white crystalline powder

Factory Supply industrial standard Terazosin hydrochloride dihydrate 70024-40-7 In Stock

  • Molecular Formula:C19H25N5O4*ClH*H2O
  • Molecular Weight:441.915
  • Appearance/Colour:white or off-white crystalline powder 
  • Vapor Pressure:1.59E-17mmHg at 25°C 
  • Melting Point:271-274 °C 
  • Boiling Point:664.5 °C at 760 mmHg 
  • Flash Point:355.7 °C 
  • PSA:121.50000 
  • LogP:2.31430 

Terazosin hydrochloride dihydrate(Cas 70024-40-7) Usage

Manufacturing Process

To a solution of n-butanol (316 ml), water (24 ml) and N-(2- tetrahydrofuroyl)piperazine (20 g) were added, while stirring, 4-amino-2- chloro-6,7-dimethoxyquinazoline (22.2 g). The reaction mixture was heated to reflux and the reflux was maintained for about 9 h. Then the reaction mixture was cooled to room temperature and stirred at this temperature for about 10- 12 h. The crystals were collected by filtration, washed with n-BuOH and dried in vacuo at 40-50°C to yield 40.1 g (94%) of the 1-(4-amino-6,7-dimethoxy- 2-quinazolinyl)-4-(tetrahydrofuroyl)piperazine hydrochloride dihydrate

Therapeutic Function

Antihypertensive

InChI:InChI=1/C19H25N5O4.ClH.2H2O/c1-26-15-10-12-13(11-16(15)27-2)21-19(22-17(12)20)24-7-5-23(6-8-24)18(25)14-4-3-9-28-14;;;/h10-11,14H,3-9H2,1-2H3,(H2,20,21,22);1H;2*1H2

70024-40-7 Relevant articles

COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING SALT SENSITIVITY OF BLOOD PRESSURE

-

, (2015/02/05)

To characterize the urinary exosome miRN...

Process for the preparation of terazosin hydrochloride dihydrate

-

, (2008/06/13)

A process for the preparation of 1-(4-am...

Terazosin crystalline polymorph and pharmaceutical compositions thereof

-

, (2008/06/13)

The present invention relates to the dis...

Process and intermediate for the preparation of terazosin hydrochloride dihydrate

-

, (2008/06/13)

A process for the preparation of 1-(4-am...

70024-40-7 Process route

2-chloro-6,7-dimethoxyquinazolin-4-amine
23680-84-4

2-chloro-6,7-dimethoxyquinazolin-4-amine

N-(tetrahydro-2-furoyl)-piperazine
63074-07-7

N-(tetrahydro-2-furoyl)-piperazine

1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-[(tetrahydro-2-furanyl)-carbonyl]piperazine monohydrochloride dihydrate
70024-40-7

1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-[(tetrahydro-2-furanyl)-carbonyl]piperazine monohydrochloride dihydrate

Conditions
Conditions Yield
In 1,4-dioxane; water;
 
In ethanol; water;
36.44 g (85.5%)
In 2-methyl-propan-1-ol; water;
39.2 g (91.9%)
In water; cyclohexanol;
 
isopropyl alcohol
67-63-0,8013-70-5

isopropyl alcohol

2-chloro-6,7-dimethoxyquinazolin-4-amine
23680-84-4

2-chloro-6,7-dimethoxyquinazolin-4-amine

N-(tetrahydro-2-furoyl)-piperazine
63074-07-7

N-(tetrahydro-2-furoyl)-piperazine

1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-[(tetrahydro-2-furanyl)-carbonyl]piperazine monohydrochloride dihydrate
70024-40-7

1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-[(tetrahydro-2-furanyl)-carbonyl]piperazine monohydrochloride dihydrate

Conditions
Conditions Yield
In water;
38.8 g (94%)

70024-40-7 Upstream products

  • 67-63-0
    67-63-0

    isopropyl alcohol

  • 23680-84-4
    23680-84-4

    2-chloro-6,7-dimethoxyquinazolin-4-amine

  • 63074-07-7
    63074-07-7

    N-(tetrahydro-2-furoyl)-piperazine

Relevant Products